Cargando…
IL-1 Receptor Antagonist (IL-1Ra) Levels and Management of Metabolic Disorders
Low-grade inflammation is a major player in obesity and the metabolic syndrome predicting development of type 2 diabetes (T2DM). The interleukin-1 receptor antagonist (IL-1Ra) is a vital and natural anti-inflammatory factor and mediator in glucose homeostasis disturbances. The predictive role is ind...
Autor principal: | Luotola, Kari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415765/ https://www.ncbi.nlm.nih.gov/pubmed/36014927 http://dx.doi.org/10.3390/nu14163422 |
Ejemplares similares
-
The effect of an interleukin receptor antagonist (IL-1ra) on colonocyte eicosanoid release
por: Smith, G. S., et al.
Publicado: (1996) -
Variation in the CXCR1 gene (IL8RA) is not associated with susceptibility to chronic periodontitis
por: Scarel-Caminaga, Raquel M, et al.
Publicado: (2011) -
Effects of leflunomide on interleukin-1 receptor antagonist (IL-1Ra) synthesis in chondrocytes and synovial fibroblasts
por: Palmer, G, et al.
Publicado: (2003) -
The Experimental Treatment of Corneal Graft Rejection with the Interleukin-1 Receptor Antagonist (IL-1ra) Gene
por: Yuan, Jin, et al.
Publicado: (2013) -
Interleukin-1B (IL-1B-31 and IL-1B-511) and interleukin-1 receptor antagonist (IL-1Ra) gene polymorphisms in primary immune thrombocytopenia
por: Yadav, Deependra Kumar, et al.
Publicado: (2017)